Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Common Equity (2016 - 2025)

Sanara MedTech's Common Equity history spans 15 years, with the latest figure at $5.9 million for Q4 2025.

  • For Q4 2025, Common Equity fell 84.76% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $5.9 million, down 84.76%, while the annual FY2025 figure was $5.9 million, 84.76% down from the prior year.
  • Common Equity reached $5.9 million in Q4 2025 per SMTI's latest filing, down from $6.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $44.6 million in Q3 2022 to a low of $5.9 million in Q4 2025.
  • Average Common Equity over 5 years is $35.3 million, with a median of $39.2 million recorded in 2024.
  • Peak YoY movement for Common Equity: surged 517.38% in 2021, then crashed 84.76% in 2025.
  • A 5-year view of Common Equity shows it stood at $30.2 million in 2021, then soared by 38.37% to $41.7 million in 2022, then grew by 6.87% to $44.6 million in 2023, then decreased by 12.73% to $38.9 million in 2024, then plummeted by 84.76% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Common Equity are $5.9 million (Q4 2025), $6.1 million (Q3 2025), and $35.4 million (Q2 2025).